Heartland Advisors’s Interpace Biosciences, Inc. Common Stock IDXG Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | – | Sell |
-29,894
| Closed | -$478K | – | 219 |
|
2016
Q3 | $478K | Sell |
29,894
-49
| -0.2% | -$784 | 0.03% | 176 |
|
2016
Q2 | $988K | Hold |
29,943
| – | – | 0.06% | 170 |
|
2016
Q1 | $838K | Sell |
29,943
-327
| -1% | -$9.15K | 0.04% | 169 |
|
2015
Q4 | $1.51M | Sell |
30,270
-1,002
| -3% | -$49.9K | 0.06% | 187 |
|
2015
Q3 | $5.66M | Buy |
31,272
+2,510
| +9% | +$455K | 0.21% | 136 |
|
2015
Q2 | $4.11M | Sell |
28,762
-25
| -0.1% | -$3.58K | 0.11% | 180 |
|
2015
Q1 | $3.89M | Buy |
28,787
+1,636
| +6% | +$221K | 0.1% | 183 |
|
2014
Q4 | $4.86M | Sell |
27,151
-2,345
| -8% | -$420K | 0.1% | 190 |
|
2014
Q3 | $7.08M | Buy |
29,496
+110
| +0.4% | +$26.4K | 0.14% | 165 |
|
2014
Q2 | $12.9M | Buy |
29,386
+132
| +0.5% | +$57.8K | 0.22% | 131 |
|
2014
Q1 | $13.4M | Buy |
29,254
+298
| +1% | +$136K | 0.23% | 133 |
|
2013
Q4 | $13.9M | Buy |
28,956
+2,935
| +11% | +$1.41M | 0.24% | 130 |
|
2013
Q3 | $12.5M | Buy |
26,021
+2,256
| +9% | +$1.09M | 0.23% | 134 |
|
2013
Q2 | $11.2M | Buy |
+23,765
| New | +$11.2M | 0.21% | 148 |
|